This study
describes a general chemoselective Suzuki–Miyaura coupling
of polyhalogenated aryl triflates with the reactivity order of C–Cl
> C–OTf using a Pd/L33 catalyst. The methine
hydrogen
and the steric hindrance offered by the alkyl bottom ring of L33 were found to be key factors in reactivity and chemoselectivity.
With the Pd/L33 catalyst, a wide range of polyhalogenated
(hetero)aryl triflates, which were independent of the substrates and
of the relative positioning of the competing reaction sites, coupled
well with (hetero)aryl, alkenyl, and alkylboronic acids to obtain
the corresponding products with good chemoselectivity and yields.
The chemoselective reaction could easily be scaled up to the gram
scale, and the use of parts per million levels of Pd catalyst (as
low as 10 ppm Pd) was achieved.
This study reports the palladium-catalyzed chemoselective borylation of (poly)halogenated aryl triflates with a reactivity order of CÀ Cl > CÀ OTf. A catalyst system comprising Pd(OAc) 2 and SelectPhos (L1) enables a reaction with high reactivity and chemoselectivity. The consecutively chemoselective borylation reaction followed by the chemoselective intermolecular Suzuki-Miyaura reaction can be performed using a one-pot two-step approach to synthesize unsymmetrical biaryl compounds containing the triflate moiety. The reaction can be scaled up to the gram scale without diminishing the yield and chemoselectivity.
This article presents a comprehensive analysis of the progress in palladium-catalyzed coupling reactions, with an emphasis on how ligand characteristics affect the chemoselectivity of aryl (pseudo)halides.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.